Sale!

Colon Cancer Comprehensive Panel NGS Genetic Test Cost

Original price was: 6,000 د.إ.Current price is: 4,400 د.إ.

-27%

The “Colon Cancer Comprehensive Panel NGS (Next-Generation Sequencing) Genetic Test” is a sophisticated diagnostic tool offered by DNA Labs UAE, aimed at identifying genetic mutations associated with an increased risk of colon cancer. This test, priced at 4400 AED, leverages the cutting-edge NGS technology to meticulously analyze multiple genes simultaneously, providing a comprehensive overview of genetic variants that may contribute to the development of colon cancer.

By examining a broad panel of genes known to be linked with colon cancer, the test offers valuable insights that can guide personalized prevention strategies, inform treatment options, and help in the management of the disease. It is particularly beneficial for individuals with a family history of colon cancer or those who have been identified as at high risk based on other genetic tests or clinical factors.

Performed in the state-of-the-art facilities of DNA Labs UAE, this test requires a simple blood sample or a cheek swab from the patient. The results from the test can help healthcare providers make more informed decisions regarding surveillance, lifestyle modifications, and, if necessary, medical interventions to reduce the risk of colon cancer.

The comprehensive nature of the test, combined with the expertise of DNA Labs UAE, makes it a valuable resource for individuals seeking to understand their genetic risk for colon cancer and take proactive steps towards their health management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Colon Cancer Comprehensive Panel NGS Genetic Test

At DNA Labs UAE, we offer the Colon Cancer comprehensive panel NGS Genetic DNA Test at a cost of AED 4400.0. This test analyzes a patient’s DNA for mutations and variations in genes that are associated with an increased risk of developing colon cancer.

Test Details

The Colon Cancer comprehensive panel NGS Genetic DNA Test uses next-generation sequencing (NGS) technology to analyze multiple genes simultaneously, providing a comprehensive evaluation of a patient’s genetic risk for colon cancer. The test typically includes analysis of genes such as APC, MUTYH, MLH1, MSH2, MSH6, PMS2, and EPCAM, among others.

Mutations or variations in these genes have been associated with an increased risk of developing colon cancer and other related cancers.

Who Should Take This Test?

The Colon Cancer comprehensive panel NGS Genetic DNA Test is typically recommended for individuals with a personal or family history of colon cancer or other related cancers. It is also recommended for those with a suspected hereditary cancer syndrome.

This test can help identify individuals who may benefit from increased surveillance or preventative measures, such as earlier and more frequent colonoscopies or prophylactic surgery.

How the Test is Conducted

The test is performed on a sample of the patient’s blood or tissue. The sample can be in the form of blood, extracted DNA, or one drop of blood on an FTA card.

After the sample is collected, it is sent to our laboratory for analysis using NGS technology. The test typically takes 3 to 4 weeks for results to be delivered.

Interpreting the Results

Once the results are available, they are interpreted by a genetic counselor or medical professional. They can provide guidance on the implications of the results and any recommended follow-up actions.

Conclusion

The Colon Cancer comprehensive panel NGS Genetic DNA Test offered by DNA Labs UAE is a valuable tool in assessing an individual’s genetic risk for colon cancer. It provides comprehensive analysis of multiple genes associated with an increased risk of developing colon cancer and related cancers.

If you have a personal or family history of colon cancer or suspect a hereditary cancer syndrome, we recommend considering this test to identify potential preventative measures or increased surveillance that may be necessary for your health.

 

Test NameColon Cancer comprehensive panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeCancer
DoctorOncologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Colon Cancer comprehensive panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APC, ATM, AXIN2, BLM, BMPR1A, BRCA1, BRCA2, CDH1, CDKN2A, CHEK2, EPCAM, FLCN, GALNT12, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS2, POLD1, POLE, PRSS1, PTEN, RNF43, SMAD4, STK11, TGFBR2, TP53, VHL
Test Details

The Colon Cancer comprehensive panel NGS Genetic DNA Test is a genetic test that analyzes a patient’s DNA for mutations and variations in genes that are associated with an increased risk of developing colon cancer. The test uses next-generation sequencing (NGS) technology to analyze multiple genes simultaneously, providing a comprehensive evaluation of a patient’s genetic risk for colon cancer.

The test typically includes analysis of genes such as APC, MUTYH, MLH1, MSH2, MSH6, PMS2, and EPCAM, among others. Mutations or variations in these genes have been associated with an increased risk of developing colon cancer and other related cancers.

The Colon Cancer comprehensive panel NGS Genetic DNA Test is typically recommended for individuals with a personal or family history of colon cancer or other related cancers, as well as those with a suspected hereditary cancer syndrome. The test can help identify individuals who may benefit from increased surveillance or preventative measures, such as earlier and more frequent colonoscopies or prophylactic surgery.

The test is performed on a sample of the patient’s blood or tissue, and results are typically available within a few weeks. The results are interpreted by a genetic counselor or medical professional, who can provide guidance on the implications of the results and any recommended follow-up actions.